Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

Discovery Science

  • American Federation for Aging Research

    American Federation for Aging Research

    The Glenn Foundation for Medical Research and the American Federation for Aging Research awarded a $300,000 grant to support basic science research by Dana-Farber’s Edward Chouchani, PhD, as he seeks to systematically define the functional targets of reactive oxygen species that contribute to longevity and age.

    Continue Reading

  • Dana-Farber Marathon Challenge accelerates basic cancer research

    Dana-Farber Marathon Challenge accelerates basic cancer research

    Around mile 20 of the 2023 Boston Marathon,® Leah Meehan was in pain from a knee injury and struggling to keep pace. Out of nowhere, a bystander ran up to her with a bowl of bananas and said, “Take one of these. It will help you.”

    Continue Reading

  • Damon Runyon supports bold research by emerging talent

    Damon Runyon supports bold research by emerging talent

    The Damon Runyon Cancer Research Foundation has awarded $1.22 million in grants to four early career investigators at Dana-Farber whose research has the potential to yield important breakthroughs in cancer prevention, diagnosis, and treatment.

    Continue Reading

  • What is basic science?

    What is basic science?

    The first step in creating cutting-edge cancer treatments for patients is basic research—scientific investigation that uncovers biology’s fundamental principles and helps us understand how the cells and molecules in our bodies work.

    Continue Reading

  • Richard and Susan Smith Family Foundation

    Richard and Susan Smith Family Foundation

    A $300,000 Odyssey Award from the Richard and Susan Smith Family Foundation provides critical resources to develop a groundbreaking platform to analyze the structure and function of disordered proteins that drive disease progression. This pioneering project promises to reveal structural biological insights while validating a powerful new tool to inform drug discovery across multiple cancers.

    Continue Reading

  • Samuel Waxman Cancer Research Foundation

    Samuel Waxman Cancer Research Foundation

    The Samuel Waxman Cancer Research Foundation awarded $200,000 to Dana-Farber to support research into how aging affects the behavior of tumor cells. This research, led by Lewis Cantley, PhD, in the Department of Cancer Biology, could provide further insight that may inform the development of age-specific treatment approaches for cancer.

    Continue Reading

  • Mathers Foundation grants promote basic cancer research

    Mathers Foundation grants promote basic cancer research

    Many of today’s important advances in cancer care trace their origins to basic research—a form of scientific investigation aimed at uncovering the fundamental principles of biology, chemistry, and foundational science.

    Continue Reading

  • The Dana-Farber Campaign

    The Dana-Farber Campaign

    Establishing an endowment is a powerful way to support The Dana-Farber Campaign.

    Continue Reading

  • Tim and Ginny Bliss endow investigatorship with $2.2 million gift

    Tim and Ginny Bliss endow investigatorship with $2.2 million gift

    Dana-Farber's Bing Center for Waldenström’s Macroglobulinemia is the world’s largest referral center for a rare blood cancer that occurs in only about 1,500 patients each year. Tim Bliss, of Santa Barbara, California, is one of them.

    Continue Reading

  • Simons Foundation grant targets cell biology

    Simons Foundation grant targets cell biology

    Scientists are often able to pinpoint genomic variants in people with disease, but it is very difficult to understand which of those mutations caused their illness, and even harder to know how that knowledge should inform treatment.

    Continue Reading